Lung cancer stem cells: a biological and clinical perspective
- 31 July 2013
- journal article
- review article
- Published by Springer Nature in Cellular Oncology
- Vol. 36 (4) , 265-275
Abstract
Lung cancer is the most lethal form of cancer in the world and despite significant therapeutic improvements that have been made, its survival rate still remains low. The latter is mainly due to the acquisition of resistance to systemic treatment regimens which, in turn, may be due to the presence of cancer stem cells (CSCs) within the primary tumors. CSCs constitute a subpopulation of cells that are highly tumorigenic and that exhibit biological properties similar to those of normal tissue stem cells, including an unlimited self-renewal capacity, an extensive proliferative capacity and a capacity to generate differentiated progeny. A better understanding of the signaling pathways that regulate lung CSC maintenance, proliferation, and tumorigenicity could thus lead to the design of improved approaches to lung cancer treatment. In this review we will discuss the current knowledge on lung CSCs, their biological properties and their putative clinical relevance. By employing currently available data, we will evaluate the prognostic value of several lung CSC markers. In addition, we will discuss the release of CSCs from tumor tissue into the blood circulation via epithelial-mesenchymal transition (EMT) as an important step towards acquiring a metastatic phenotype. Finally, we will provide an outlook into novel CSC-targeting approaches for achieving less invasive diagnostic procedures and improving long-term therapeutic options. Lung CSC research has gained considerable momentum to both basic and clinical applications, both aiming to identify a reliable panel of markers for lung CSCs and to clarify their function, with the final goal to develop a CSC-targeted therapy that will result in the complete elimination of CSCs for achieving significantly better long-time survival of lung cancer patients.Keywords
This publication has 113 references indexed in Scilit:
- Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem CellsStem Cells, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem CellsStem Cells, 2010
- Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapyCancer and Metastasis Reviews, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinomaClinical & Experimental Metastasis, 2009
- Aldehyde dehydrogenase activity as a functional marker for lung cancerChemico-Biological Interactions, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Lung epithelial stem cellsThe Journal of Pathology, 2002